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Neurodegenerative disorders such as Huntington’s disease are hallmarked by neuronal intracellular
inclusion body formation. Whether proteasomes are irreversibly recruited into inclusion bodies in
these protein misfolding disorders is a controversial subject. In addition, it has been proposed that
the proteasomes may become clogged by the aggregated protein fragments, leading to impairment
of the ubiquitin–proteasome system. Here, we show by ﬂuorescence pulse-chase experiments in liv-
ing cells that proteasomes are dynamically and reversibly recruited into inclusion bodies. As these
recruited proteasomes remain catalytically active and accessible to substrates, our results challenge
the concept of proteasome sequestration and impairment in Huntington’s disease, and support the
reported absence of proteasome impairment in mouse models of Huntington’s disease.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Huntington’s disease (HD) is caused by a polyglutamine (polyQ)
expansion in the disease-related huntingtin (HTT) protein, and is
hallmarked by inclusion body (IB) formation in neurons [1,2]. N-ter-
minal fragments of the mutant HTT (mHTT) protein containing the
expanded polyQ repeat are thought to initiate IB formation and sub-
sequently sequester components of the ubiquitin–proteasome sys-
tem (UPS) [1,3–5]. This proteasome sequestration into IBs is
considered to contribute to HD pathology through the disruption
of UPS function [6–8]. Fluorescence recovery after photobleaching
(FRAP) experiments have suggested that the sequestration of ﬂuo-
rescently-taggedproteasomes into IBs is irreversible [9]. In addition,
in vitro data have suggested that proteasomes cannot cleave withinpolyQ repeats in polyQ-expanded proteins. As a consequence, it is
proposed that pure polyQ fragments are released into the cell that
may subsequently act as initiators of aggregation [10,11]. UPS
impairment has been observed both in cultured cells and in HD pa-
tientmaterial andmay indeedbe causedby the sequestration of pro-
teasomes into IBs that are initiated by expanded polyQ fragments
[11–14]. However, robust proteasome impairment has not been de-
tected in HD mouse models after IB formation [15–17]. To examine
whether proteasomes are indeed irreversibly sequestered into pol-
yQ IBs, we visualized proteasome dynamics in IBs by ﬂuorescent
pulse-chase experiments. In addition, we used proteasome activity
based probes to visualize proteasome accessibility and activity in
the IBs of individual cells and in the brains of HD mice.
2. Materials and methods
2.1. DNA constructs
mHTT(Q97)exon1 was generated by replacing the C-terminal
GFP sequence of polyQ-expanded mHTTexon1-GFP (kindly
provided by Prof. RR. Kopito, Stanford University, USA) for a
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Q103 was generated as described previously [10]. Ub-Q99-C4
was generated by introducing a C4-tag after GFP-Ub-Q99 using
two annealed C4-primers, forward 50-GATCTGTTTCTTAATTGTTGTC
CTGGTTGTTGTATGGAACCTTAAT-30 and reverse 50-CTAGATTAAGG
TTCCATACAACAACCAGGACAACAATTAAGAAACA-30. PSMB4-mRFP
was kindly provided by Prof. NP. Dantuma (Karolinski Institute,
Stockholm, Sweden), and the PSMB4-GFP and PSMB4-C4
constructs were generated by replacing the mRFP for an eGFP or
C4-tag.2.2. Cell culture and transfection
HeLa, Mel JuSo (melanoma) and HEK293 cells were cultured in
DMEM supplemented with 10% fetal calf serum at 37 C in a 5% CO2
atmosphere. HEK293 cells were transfected with jetPEI (Polyplus
transfection), HeLa and Mel Juso cells were transiently transfected
with HD Fugene as described by the manufacturer (Roche Applied
Sciences, Mannheim, Germany). For confocal microscopy imaging
cells were grown on 2 cm coverslips (Menzel Glaser, Braun-
schweig, Germany) in 6-well plates.2.3. Biarsenical labeling and confocal imaging
At 48 h after transfection, HeLa and Mel JuSo cells were stained
as described by Martin et al. [18]. Brieﬂy, 1 mM ReAsH which was
pre-incubated in 10 mM 1,2-ethanedithiol (EDT, Sigma–Aldrich,
Sigma–Aldrich, Steinheim, Germany) in dimethyl sulfoxide
(DMSO) for 10 min. Subsequently, cells were washed using PBS
(GIBCO/Invitrogen, Breda, The Netherlands) and incubated for
45 min at 37 C with 1 lM ReAsH in Optimem (GIBCO/Invitrogen,
Breda, The Netherlands), followed by 4 washes at RT in wash med-
ium (complete DMEM medium with 1 mM EDT). Mel Juso cells
were ﬁxed with 2% paraformaldehyde (EMS, Hatﬁeld, PA, USA) in
1 PBS (GIBCO/Invitrogen, Breda, The Netherlands) prior to label-
ing and HeLa cells were ﬁxed after labeling. Samples were exam-
ined using a Leica TCS SP2 confocal microscope equipped with
Ar/Kr laser and 40 or 63 objective (Leica Microsystems, Mann-
heim, Germany).2.4. Native gel analysis
HEK293 cells were harvested in TSDG buffer (10 mM Tris pH7.5,
25 mM KCl, 10 mM NaCl, 1.1 mM MgCl2, 0.1 mM EDTA and 8%
glycerol) and lysed by 3 freeze/thaw cycles in liquid nitrogen. After
centrifugation (15 min, 20.817g) the concentration of the super-
natant was determined by a Bradford protein assay (Serva, Heidel-
berg, Germany). Proteasomes were labeled in the lysate using
0.5 lM ABP2 (bodypi-epoxomicin) [19] for 1 h at 37 C. 4 native
sample buffer (20 mM Tris pH 8.0, 50% glycerol, 0.1% bromophenol
blue) was added to 30 lg lysate. The samples were loaded on a 4–
12% Creterion XT Precast Bis–Tris gel (Biorad, Hercules, CA, USA)
and ran for 4 h at 180 V. Fluorescence imaging was performed on
a Trio Thyphoon (GE Healthcare) using the 580 BP 30 ﬁlter to de-
tect the bodypi-epoxomicin probe and mRFP, the 610 BP 30 ﬁlter
to detect ReAsH and the 520 BP 40 ﬁlter for GFP detection. For wes-
tern blotting the gels were incubated 0.5 h in transfer buffer with
SDS added (25 mM Tris pH 7.5, 192 mM Glycine, 20% MeOH and
0.1% SDS) and transferred to a PVDF membrane (Millipore, Bedford,
MA, USA).PSMA2 (a2) proteins were detected by the MCP236 anti-
body (1:1000) (kindly provided by Rasmus Hartmann-Petersen,
Biologisk Institut, University of Copenhagen), and detection was
done by the Odyssey detection system (LICOR Bioscienses, Lincoln,
NE, USA).2.5. Confocal FLIM
We used EGFP and the red biarsenical ﬂuorophore ReAsH as a
FRET pair. Data was acquired using an Olympus IX81 inverted
microscope with a FV1000 scan- and confocal detection head, con-
trolled by FV2.3 software. Donor ﬂuorophores were excited using a
440 nm 20 MHz pulsing laser diode (Picoquant, Berlin, Germany),
as controlled by a SepiaII laser driver unit (Picoquant, Berlin, Ger-
many) and attenuated 10 times by a neutral density ﬁlter. The light
was guided via a D405/480/560/635 primary dichroic mirror
(Chroma, Brattleboro, VT, USA) through a water immersed 60x UP-
lanS-Apo objective (NA 1.2) into the sample. Cellular samples were
grown on 24 mm round coverslips (Menzel Glaser, Braunschweig,
Germany), ﬁxed in 2% paraformaldehyde (EMS, Hatﬁeld, PA, USA)
and stored in PBS (GIBCO/Invitrogen, Breda, The Netherlands).
The emission light was guided via a size-adjustable pinhole, set
at 120 lm, through the Olympus detection box to the ﬁbre output
channel. The optical ﬁbre was coupled to a custom-made detection
box (Picoquant, Berlin, Germany) containing MPD avalanche pho-
todiodes. The light was guided into one of the MPDs and ﬁltered
by a 525/45 emission ﬁlter (Chroma, Brattleboro, VT, USA). The
photon arrival times were recorded by a Picoharp 300 time-corre-
lated single-photon counting system (Picoquant, Berlin, Germany)
and analysed in SymPhoTime 5.13 software (Picoquant, Berlin,
Germany). For each ROI the ﬂuorescence decay curve was ﬁtted
using a mono-exponential decay ﬁt, including the estimated
instrument response function (IRF) and a background term. For
data analysis only ﬂuorescence decays having more than 10000
registered photons in the peak were considered and the quality
of the ﬁt was judged by visual inspection of the ﬁtresiduals and
the normalized Chi2 value.
2.6. Soluble and insoluble fraction analysis
HEK293 cells were lysed in 1xTEX buffer (70 mM Tris pH 6.8,
1.5% SDS, 20% glycerol) and sonicated by the Soniprep150 (Sanyo,
Leicester, UK), 50 mM DDT was added and samples were boiled
for 10 min prior to 1 h centrifugation at 20817g at RT. The pel-
leted fraction, representing the insoluble fraction, was incubated
with 10 ll 100% formic acid, incubated at 37 C for 30 min and
lyophilized for o/n in a speedvac (Eppendorf, Hamburg, Germany).
1xTEX buffer was added to the pellet, following the soluble and
insoluble fractions, which were supplemented with 0.05% bromo-
phenol blue, were loaded on a 12.5% SDS–page gel. Polyglutamine
stretches were detected by the 1C2 antibody (MAB 1574, 1:1000,
Millipore, Bedford, MA, USA), PSMA2 detection was done by the
MCP236 antibody (1:1000, kindly provided by R. Hartmann-Peter-
sen, University of Copenhagen, Denmark) and b-actin detection
was done by N-21 (130656, 1:1000, Santa Cruz, Santa Cruz, CA,
USA). For activity labeling cells were incubated in complete med-
ium with 0.5 lM ABP2 at room temperature after harvesting. Sub-
sequently, cells were washed in PBS (GIBCO/Invitrogen, Breda, The
Netherlands), collected and treated like the above mentioned pro-
cedure. For activity labeling of brain samples, the cerebral cortex
was ﬁrst homogenized in 500 ll TSDG buffer (10 mM Tris pH7.5,
25 mM KCl, 10 mM NaCl, 1.1 mM MgCl2, 0.1 mM EDTA and 8%
glycerol) and incubated with ABP2 for 1 h at 37 C. 170 ll 1xTEX
buffer was added to 30 ll lysate and subsequently treated as for
the above mentioned procedure. After running the samples on a
12.5% SDS gel, the wet gel slap was scanned for ﬂuorescence and
further subjected for Western blotting.
2.7. Pulse-chase experiments
HeLa cells were labeled with ReAsH as described above to stain
the pre-existing pool of C4-tagged proteins. After the washing step,
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um supplemented DMEM. Following the chase period, newly syn-
thesized proteins were labeled with FlAsH by the same procedure.
Subsequently, cells were ﬁxed in 2% paraformaldehyde (EMS, Hat-
ﬁeld, PA, USA), embedded in Vectashield containing DAPI (Vector
Laboratories, Burlingame, CA, USA) and analyzed by confocal
microscopy, using Huygens essentials software (BioVision technol-
ogies, Exton, PA, USA) to determine ﬂuorescence intensities of the
cross sections.
2.8. Proteasome activity labeling in living cells
Mel JuSo cells were incubated for 1 h at 37 C in serum free
medium supplemented with 0.25 lM ABP1 (BodypiFL-Ahx3L3VS)
[20]. Cells were subsequently washed 3 times in PBS (GIBCO/Invit-
rogen, Breda, The Netherlands) and ﬁxed in 2% paraformaldehyde
(EMS, Hatﬁeld, PA, USA) prior to ReAsH staining.
2.9. Activity labeling in gel
HEK293 cells were harvested in TSDG buffer (10 mM Tris pH
7.5, 25 mM KCl, 10 mM NaCl, 1.1 mM MgCl2, 0.1 mM EDTA and
8% glycerol), lysed by three freeze/thaw cycles in liquid nitrogen
and protein levels were determined by a Bradford assay (Serva,
Heidelberg, Germany). 40 lg of cell lysates were incubated with
0.5 lM ABP1, 0.5 lM Epoxomicin or similar amounts of DMSO
for 1 h at 37 C. Samples were loaded on a 4–12% Creterion XT Pre-
cast Bis–Tris gel (Biorad, Hercules, CA, USA) and subsequently
scanned for ﬂuorescence on a Typhoon imager (GE Healthsciences)
using the 520 BP 40 ﬁlter. The wet gel slab was incubated for
20 min in 20 ml Overlay buffer (20 mM Tris pH 7.5, 5 mM MgCl2,
1 mM ATP and 0.25 lM ABP1 and washed for 3 h in Destain buffer
(5% acetic acid, 20% MeOH). the wet gel slabs were transferred to
PVDF membrane (Millipore, Bedford, MA, USA) and western blot-
ting was performed as described above.
2.10. Mouse maintenance and breeding, genotyping and CAG repeat
sizing
Hemizygous R6/2 mice were bred by backcrossing R6/2 males
to (CBA  C57BL/6) F1 females (B6CBAF1/OlaHsd, Harlan Olac, Bic-
ester, UK). All animals had unlimited access to food and water
(breeding chow, Special Diet Services, Witham, UK), were subject
to a 12-h light/dark cycle and housing conditions and environmen-
tal enrichment were as previously described [21]. Experimental
procedures were in accordance with UK Home Ofﬁce regulations.
Genomic DNA was isolated from an ear-punch and R6/2 mice were
genotyped by PCR and the CAG repeat length was measured as pre-
viously described [22].
2.11. Activity labeling in vivo
Freshly frozen brains of 4 and 14-week-old R6/2 mice
(mHTT(Q217)) and littermate controls were used [23]. 10 lm thick
brain slices were mounted on 1 mm thick PEN membrane slides
(Zeiss, Oberkochen, Germany), dried for 10 min at room tempera-
ture and stored at 20 C until further use. Sections were incu-
bated for 10 min with 1 lM ABP1 in 10 mM PBS. After 3
washing with PBS, sections were ﬁxed with 4% paraformaldehyde
(EMS, Hatﬁeld, PA, USA). Next, sections were pre-incubated in per-
meabilization buffer (1% BSA, 2% FCS and 0.3% Triton-X 100) for 1 h
and incubated with antibodies against the N-terminal region of
mHTT-exon1 (N18, sc-8767, 1:500, Santa Cruz, Santa Cruz, CA,
USA) and proteasomal alpha and beta subunits (ab22673, abcam,
Cambridge, MA, USA) for 2 h. Sections were washed and incubated
with Cy3- or Dylight649-labeled secondary antibodies (1:1400,Invitrogen). After washing, the samples were embedded in Vecta-
shield containing DAPI (Vector Laboratories, Burlingame, CA,
USA) on 24  60 mm coverslips. Images of the cortical region were
analyzed by using a Leica TCS SP8 X Confocal Microscope (Leica
Microsystems, Mannheim, Germany). The whole procedure was
conducted at room temperature.3. Results
3.1. Proteasomes interact directly with polyQ peptides when recruited
into IBs
To examine the distribution patterns of intracellular protea-
someswithin polyQ IBs, we initiated aggregation using theN-termi-
nal exon1 fragment of polyQ-expanded mHTT (mHTT(Q97)exon1),
whichwas recently shown to be generated through themis-splicing
of the HTT gene [24] and is of a comparable size to N-terminal HTT
fragments that have been detected in the brain tissue of HD patients
[1,25]. Since it is presumed that proteasomes are unable to degrade
thepolyQ tract [10,11], purepolyQpeptides, that represent products
discharged from the proteasome, were also used as initiators of
aggregation. The Ub-Q99 constructs release Q99 peptides directly
upon synthesis, as ubiquitin is cleaved off by ubiquitin C-terminal
hydrolases [26]. The GFP-tagged proteasomal subunit PSMB4 (b7)
was used to visualize proteasomes in living cells. This subunit is efﬁ-
ciently incorporated in both 20S and 26S proteasomes, as shown by
complex separation on a native gel and subsequent analysis of ﬂuo-
rescence (Supplementary Fig. S1). Recruitment of proteasomes into
mHTT initiated IBs was observed when the PSMB4-GFP was co-ex-
pressed with tetracysteine-tagged mHTT (mHTT(Q97)exon1-C4).
WhenmHTT(Q97)exon1-C4was labeledwith thebiarsenical ﬂuoro-
phore ReAsH [18], itwas predominantly found in the core of IBs. Pro-
teasomesweredifferentlydistributeddependent on IB size (Fig. 1A):
in that they colocalized with mHtt(Q97)exon1-C4 in smaller IBs
(Fig. 1A, upper panel), but were located in the outer layers of the lar-
ger IBs, forming a ring-like structure (Fig. 1A, lower panel). A similar
redistribution of proteasomes was observed in cells stably express-
ing a7-GFP, which was used as an alternative proteasomal subunit
(data not shown). When C4-tagged polyQ peptides were used (Ub-
Q99-C4), a similar proteasomal distribution pattern was observed
(Fig. 1B). These ﬁndings suggest that proteasomes are not irrevers-
ibly trapped, but remain at the periphery of expanding IBs.
To determine whether these proteasomes interact directly with
polyQ peptides, both in the core and in the periphery of IBs, we
used ﬂuorescence lifetime imaging microscopy (FLIM) to study
proteasome-polyQ interactions. Previously, we have shown by
wide-ﬁeld FRET–FLIM microscopy that while GFP-tagged protea-
somes, ubiquitin and the chaperone HSP70 were all recruited into
polyQ aggregates, only GFP-tagged proteasomes directly interacted
with polyQ fragments whereas GFP-ubiquitin and HSP70-GFP only
showed modest reductions in ﬂuorescence lifetime [27]. By using
confocal FRET–FLIM, we could distinguish between protein inter-
actions in the core of the IB and at the periphery of IBs. Co-expres-
sion of ReAsH-labeled Ub-Q99-C4 and GFP-tagged PSMB4 showed
a signiﬁcant decrease in GFP donor lifetime compared to the neg-
ative control (Ub-Q103), both when proteasomes were present in
the core or in the ring-like structures of IBs (Fig. 1C). This indicates
that while the chaperone HSP70 does not interact directly with
polyQ peptides in IBs, proteasomes interact with polyQ fragments
both at the early stage of IB formation and during later stages.
3.2. Proteasomes are dynamically recruited into polyQ initiated IBs
To visualize proteasome dynamics in IBs, we performed a ﬂuo-
rescence pulse-chase experiment. Since it had been demonstrated
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somes within IBs over a time span of minutes [9], we chose to
study changes in protein distribution over a time span of hours.
We ﬁrst labeled the pre-existing pool of the C4-tagged proteins
(mHTT(Q97)exon1-C4, UbQ99-C4 and PSMB4-C4) with the red
ﬂuorescent dye ReAsH. After a subsequent chase period of 8 or
20 h to allow synthesis of new C4-tagged proteins, the cells were
incubated with the green ﬂuorescent dye FlAsH to label these new-
ly-synthesized proteins. Pulse-chase labeling of mHTT(Q97)exon1-
C4 (Fig. 2A) or Ub-Q99-C4 (Fig. 2E) showed a sequential sequestra-
tion of these polyQ fragments, as the newly synthesized
mHTT(Q97)exon1-C4 or polyQ-C4 peptides were recruited to the
outer layers of the IBs, whereas the initial polyQ fragments were
exclusively found in the core of the IB, both after an 8 and 20 h
chase period. The difference in distribution was not due to uneven
penetration of FlAsH and ReAsH, as both dyes efﬁciently label the
core of Q99-C4 aggregates [27]. In contrast, C4-tagged proteasomes
(PSMB4-C4) showed a different distribution pattern in IBs that
were initiated by co-expression of untagged mHTT(Q97)exon1
(Fig. 2C) or polyQ peptides (Fig. 2F). After an 8 h chase period, there
was a partial overlap between the pre-existing and newly-synthe-
sized proteasomes. After a 20 h chase period, a complete overlap in
localization of both proteasome pools in the ring-like structures
was observed. This demonstrates that the initial ReAsH-labeledpool exchanged with the newly-synthesized FlAsH-labeled pool
of proteasomes, indicating that proteasomes are dynamic within
IBs. Fluorescence intensity plots of cross sections of the IBs show
the difference in localization of the initial pool (red) and the chased
pool (green) of mHTT(Q97)exon1-C4 or proteasome subunit
PSMB4-C4 (Fig. 2B and D, respectively). The difference in
recruitment between proteasomes and mHTT was also shown
biochemically. Proteasomes were present only in the SDS-soluble
fraction of cells expressing mHTT(Q97)exon1, whereas polyQ
proteins were present in both the SDS-soluble and SDS-insoluble
fraction (Supplementary Fig. S2). Together, these ﬁndings show
that proteasomes are not irreversibly trapped in mHTT IBs, but
are dynamically recruited albeit with relatively low exchange
rates.
3.3. Proteasomes recruited into IBs are still catalytically active and
accessible
The dynamic recruitment of proteasomes into IBs and the direct
interaction between proteasomes and polyQ fragments does not
exclude the possibility that proteasomes may become catalytically
impaired due to clogging by polyQ fragments, as previously sug-
gested [9,11]. To examine whether proteasomes remain active
and accessible for substrates in IBs, we added the activity based
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rescent ABP covalently labels all three catalytic subunits of protea-
somes when the active sites are accessible, allowing detection via
ﬂuorescence. When cells expressing mHTT(Q97)exon1-C4 or Ub-
Q99-C4 were incubated with ABP1, proteasomes in both the smal-
ler and larger IBs were labeled (Fig. 3A). The activity labeling also
co-localized with proteasomes that were visualized via RFP-tagged
PSMB4, indicating catalytically inactive proteasomes did not re-
main in the dense IB core (Fig. 3B). To further examine whetherthe activity-labeled proteasomes are also accessible to substrates,
we preformed zymography to identify proteasome complexes that
are labeled by the activity probe (Fig. 3C). All proteasome
complexes were labeled by ABP1 when cell lysates were incubated
with the probe prior to native gel electrophoresis (left panel).
However, uncapped 20S proteasomes were not labeled with
ABP1 when the probe was added after separation of the different
proteasome complexes by electrophoresis (Fig. 3, right panel). This
indicates that proteasome labeling with ABP1 only occurs when
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B
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C
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Fig. 3. Proteasomes recruited into polyQ initiated IBs are catalytically active and accessible. (A) IBs recruit active proteasomes. The catalytic sites of proteasomes in IBs
initiated by mHTT(Q97)exon1-C4 (left) or Ub-Q99-C4 (right), were labeled with the green ﬂuorescent proteasome activity probe ABP1. The upper panel represents labeling of
small IBs with proteasomes present in the core, the lower panel shows activity labeling of proteasomes present in the periphery of larger IBs. (B) Proteasome distribution in
IBs colocalizes with proteasome activity probe labeling. IBs were initiated by mHTT(Q97)exon1 (left) or Ub-Q103 (right) and proteasomes were visualized using the subunit
PSMB4-RFP (red). ABP1 was added 48 h after transfection (green). (C) Activity probe labeling requires proteasome activator 19S or PA28 for entry into proteasomes. The ﬁrst
panel displays a ﬂuorescence scan before zymography, the second panel displays a ﬂuorescence scan after zymography. Lane 1 shows cell lysate that was pre-incubated with
ABP1 before separation on the native gel, where latent 20S proteasomes (arrow head) and proteasomes capped with proteasome activators 19S and PA28 (arrows) show
activity labeling. Lane 2 shows cell lysates that were incubated with ABP1 after separation on native gel using zymography, with only 19S or PA28 capped proteasomes being
labeled by the activity probe. Lane 3 contains lysates pre-incubated with proteasome inhibitor, showing reduced activity labeling. The third panel shows immunostaining for
PSMA2 subunits, indicating that the latent 20S complex (arrow head) was present in all lanes. The fourth panel depicts immunostaining of PA28a-capped complexes.
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caps. Since the probe needs access to the 20S core via these activa-
tor caps, activity labeling in IBs can therefore only occur when 20S
proteasomes are activated and accessible for protein substrates,
representing functional proteasomes. In addition, subsequent anal-
ysis by SDS gel electrophoresis under reducing conditions demon-
strated that all three proteasomal catalytic subunits remained
equally active in cells with mHTT(Q97)exon1-C4 or Ub-Q99-C4 ini-
tiated IBs (Supplementary Fig. S3).
3.4. IBs in mHtt transgenic mouse brains recruit active proteasomes
To translate our ﬁnding to an in vivo model, we examined brain
sections of 4 and 14 week old transgenic R6/2 mice that express anexon1 HTT protein with approximately 200 glutamines [23]. Both
the cerebral cortex and striatum in R6/2 mice are rich in mHTT-in-
duced IBs and in order to determine proteasome activity labeling in
neuronal IBs, immunohistochemistry was used for identiﬁcation of
proteasomes in cortical IBs, while ABP incubation was used to visu-
alize proteasome activity. In 4 week old R6/2 mice, small mHTT IBs
with an average diameter between 1 and 2 lm were detected
using the N18 antibody (Fig. 4A, upper panel). These small IBs were
mainly distributed in the cytoplasm of cells. Detection of protea-
somes via antibody staining did not show colocalization of protea-
somes in these small IBs but only a diffused intracellular
distribution, similar to the proteasome staining in 4 week old wild
type mice (Fig. 4B). Activity labeling with ABP1 also failed to show
proteasome labeling in IBs, indicating that proteasomes are not
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Fig. 4. Proteasomes recruited into inclusion bodies in the cerebral cortex of R6/2 HD transgenic mice are catalytically active. (A) Activity labeling of proteasomes in cortical
sections. Freshly frozen brain sections of 4 week and 14 week old transgenic R6/2 (mHTT(Q217)) mice were incubated with the proteasome activity probe ABP1.
Subsequently, proteasomes and mHTT were identiﬁed by immunohistochemistry, using the N18 antibody against the N-terminal region of mHTT and ab22673 against
proteasomal alpha and beta subunits. In brain sections of 4 week old R6/2 mice, mHTT was both distributed throughout the nucleus or in small IBs (upper panel). No antibody
staining and activity labeling of proteasomes was detected in IBs at this stage. In 14 week old R6/2 mice, colocalization of N18, ab22673 and probe labeling conﬁrmed the
presence of active proteasomes in neuronal IBs in the cerebral cortex (lower panel). (B) Proteasomal distribution in 4 week old wild type mice. Brain sections were incubated
with ABP1 and immunostained for mHTT and proteasomes. There is a similar proteasomal distribution to that observed in 4 week old R6/2 mice. (C) Activity labeling is
reduced after proteasomal inhibition. Brain sections of 14 week old R6/2 mice were ﬁrst incubated with epoxomycin before ABP1 was added, resulting in reduced activity
labeling in IBs. Scale bar = 10 lm. (D) Proteasomes remain equally active in brain samples of wild type mice, 4 week old R6/2 and 14 week old R6/2 mice. Cortical brain
samples were homogenized and incubated with ABP1. Subsequently, the lysate was divided into SDS soluble and insoluble fractions. Blotting for polyQ repeat sequences
(1C2) showed that mHTT was present in both fractions, while staining for proteasome levels (PSMA2) showed that proteasomes were only present in the soluble fraction.
Activity labeling of the proteasome pool showed an equal labeling efﬁciency, indicating that proteasomes remain equally active in 14 week old wild type and R6/2 mice.
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in R6/2 mice. When cortical brain sections of 14 week old R6/2
mice were examined, proteasome recruitment and activity labelingwas detected in IBs. These IBs had a larger diameter of 2.5–3 lm
and were mainly present in the nuclei (Fig. 4A, lower panel).
Quantiﬁcation of IBs that were positive for proteasome activity
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tive for ABP1, and 87% (±5%, S.D.) of the cytoplasmic IBs contained
activity labeled proteasomes. When the tissues were pre-incubated
with the proteasome inhibitor epoxomycin, the speciﬁcity of pro-
teasome activity labeling was conﬁrmed as the ﬂuorescence label-
ing decreased (Fig. 4C). To examine whether proteasome
recruitment into IBs was irreversible or caused an intracellular loss
of proteasomal activity, brain lysates were separated into SDS sol-
uble and SDS insoluble fractions. While the major pool of mHTT
was present in the soluble fraction of the 4 week old R6/2 mice,
14 week old R6/2 mice showed less mHTT in the soluble fraction
and a large increase in the insoluble fraction (Fig. 4D). Since the ly-
sates were incubated with ABP1, activity labeling could be deter-
mined by scanning the gel for ﬂuorescence after electrophoresis.
Both proteasomes and proteasomal activity labeling could not be
detected in the SDS insoluble fraction, conﬁrming that, unlike
mHTT fragments, proteasomes were not irreversible sequestered.
Since proteasome activity labeling in the soluble fractions was sim-
ilar between wild type mice and R6/2 mice of 4 or 14 weeks old,
this demonstrates that proteasomes are not impaired in these dif-
ferent stages of HD.
4. Discussion
When we visualized the dynamics of proteasomes that had
been recruited into IBs over a time span of hours, a proteasome ex-
change was observed (Fig. 2C). This is in contrast to earlier FRAP
experiments in living cells that had not shown recovery of ﬂuores-
cently-tagged proteasomes when experiments were conducted
over a time span lasting minutes [9]. This indicates that protea-
somes have a slow on–off rate into IBs, which was also supported
by the altered distribution of ﬂuorescently-tagged proteasomes in
differently-sized aggregates (Fig. 1A). Our data is in agreement
with the assumed protective role of IB formation, which was
shown when aggregating GFP-tagged mHTT fragments in striatal
neurons were imaged in time by automated ﬂuorescence micros-
copy [28]. Here, cell survival was better in cells that showed IB for-
mation when compared to cells that showed a diffuse mHTT
distribution but no visible aggregates. IB formation also coincided
with less proteasomal impairment, which was detected using a
short-lived UPS reporter [29]. A drop in the rate of degradation
of these reporters was only observed just before IBs were formed,
indicating that IB formation could indeed be a protective mecha-
nism to sequester toxic mHTT species in the cell that may other-
wise compete with regular substrates for the UPS.
The observed recruitment of proteasomes into IBs appears to be
independent of ubiquitination of the aggregated polyQ fragments.
Aggregates induced by mHTT [30] but also by pure polyQ peptides
[10] are initially devoid of ubiquitin, while proteasomes are rapidly
recruited when small aggregates are formed. While we show that
the recruited proteasomes remain catalytically active and accessi-
ble for substrates, a competition between regular UPS substrates
and aggregating mHTT might affect the turn-over of other intracel-
lular proteins, which would explain the increase in half-lives of
various short-lived UPS reporters [29,30]. This is independent of
the activity of the proteasome itself, which is not affected during
the different stages of HD (Fig 4D).
Our observation that proteasomes which are recruited into IBs
remain active and accessible seems in contrast to earlier reports
that suggest that proteasomes can become impaired due to unsuc-
cessful attempts to degrade polyQ proteins [11]. When examining
polyQ protein degradation by proteasomes in vitro and in living
cells, it was suggested that proteasomes may actually be unable
to degrade the polyQ repeat present in the proteins. The undi-
gested, expanded polyQ peptide derived from a degraded mHTTfragment may not be secreted by the proteasome, resulting in pro-
teasomal impairment. A stable interaction between ﬂuorescently-
tagged proteasomes and ﬂuorescent mHTT fragments was indeed
observed by FRET microscopy [9], although this could also be due
to a reversible interaction when proteasomes act on mHTT in IBs,
as shown by FLIM microscopy (Fig. 1C). Importantly, our ﬂuores-
cent pulse-chase experiments show that these interactions are
reversible since there is an exchange of proteasomes at the periph-
ery of IBs, in contrast to mHTT and polyQ peptides that become
irreversibly trapped in IBs.
PolyQ fragments that enter the proteasome appear to be efﬁ-
ciently degraded, since less aggregation is observed when polyQ-
expanded proteins like mHTT are targeted towards the proteasome
[31]. This indicates that the proteasome can indeed deal with pol-
yQ-expanded proteins, which is in line with our results showing
that proteasomes recruited into IBs remain catalytically active
and accessible for substrates. The dynamic recruitment of active
proteasomes to IBs may also occur in other protein-folding dis-
eases such as Parkinson’s disease and ALS. Therefore, up-regulation
of the UPS may be a potential therapeutic target to slow down dis-
ease progression.
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